Proctos Kliniek, Bilthoven, The Netherlands.
Vrije Universiteit Brussel, Brussels, Belgium.
Tech Coloproctol. 2020 Apr;24(4):291-300. doi: 10.1007/s10151-020-02156-2. Epub 2020 Feb 28.
The aim of the present study was to develop and evaluate the reliability and validity of proctology patient-reported outcome measurements (PROM): Proctoprom.
Development of the Proctoprom was based on interview rounds with experts (n = 4) and patients (n = 19) in open informal interview rounds regarding content and form. Once consensus was achieved on five items, data were collected between July 2014 and August 2016 from 991 patients recruited consecutively in a specialized proctology center. Reliability, construct validity and responsiveness of the PROM were determined through exploratory factor analysis, test-retest analysis and anchor-based hypothesis testing. We also estimated discriminant validity, standard error of measurement (SEM), minimal detectable change (MDC95%) and minimal clinically important difference (MCID).
The five items loaded on one factor that reflected good internal consistency (Cronbach's α 0.81). Test-retest analysis showed good reliability with intraclass correlation of 0.81. Construct validity measurement resulted in AUCs of 0.85 and 0.90. Responsiveness measurement resulted in AUCs of > 0.76 for both hypotheses. SEM was estimated at 3.0 points and MDC at 4.8 points. We estimated an MCID of 10 points.
Proctoprom is a valid and reliable tool that is responsive to change and that meets consensus-based standards for the selection of health measurement instruments. It can be used to evaluate disease burden and effect of treatment in all adult proctology patients regardless of their proctologic diagnosis.
本研究旨在开发和评估肛肠病患者报告结局测量(PROM):Proctoprom 的信度和效度。
Proctoprom 的开发是基于对专家(n=4)和患者(n=19)的访谈回合,这些患者接受了关于内容和形式的开放式非正式访谈回合。一旦就五项条目达成共识,便在 2014 年 7 月至 2016 年 8 月期间,在一家专门的肛肠病中心连续招募了 991 名患者,收集数据。通过探索性因子分析、重测分析和基于锚的假设检验,确定了 PROM 的信度、结构效度和反应度。我们还估计了判别效度、测量标准误差(SEM)、最小可检测变化(MDC95%)和最小临床重要差异(MCID)。
五项条目集中在一个反映出良好内部一致性的因子上(Cronbach's α=0.81)。重测分析显示具有良好的可靠性,组内相关系数为 0.81。结构效度测量的 AUC 值为 0.85 和 0.90。两个假设的反应度测量的 AUC 值均大于 0.76。SEM 估计为 3.0 点,MDC 为 4.8 点。我们估计 MCID 为 10 点。
Proctoprom 是一种有效且可靠的工具,对变化敏感,符合健康测量工具选择的共识标准。它可用于评估所有成年肛肠病患者的疾病负担和治疗效果,无论其肛肠病诊断如何。